Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Navamedic ASA ( (DE:N1A) ) has issued an update.
Navamedic ASA has announced the expiration of the subscription period for its partly underwritten rights issue, involving up to 6,046,511 new shares at a subscription price of NOK 21.50 per share. This rights issue is a strategic move to bolster the company’s financial position, potentially impacting its market operations and stakeholder interests by enhancing its capital base.
More about Navamedic ASA
Navamedic ASA is a full-service provider of high-quality healthcare products to hospitals and pharmacies. The company addresses specific medical needs of patients and consumers through its scalable market access platform, category competence, and local knowledge. Navamedic operates in the Nordic countries, the Baltics, and Benelux, with sales representation in Greece, and is headquartered in Oslo, Norway.
YTD Price Performance: -14.93%
Average Trading Volume: 14,542
Current Market Cap: NOK509.7M
Learn more about N1A stock on TipRanks’ Stock Analysis page.